Guidance

NHS pharmaceutical services: assessing applications

Guidance to help NHS England in assessing applications to provide NHS pharmaceutical services.

Documents

Chapter 5: current needs

Chapter 6: future needs

Chapter 8: unforeseen benefits

Chapter 10: relocations that do not result in significant change to pharmaceutical services provision

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk . Please tell us what format you need. It will help us if you say what assistive technology you use.

Chapter 12: changes of ownership

Chapter 14: provision of pharmaceutical services in controlled localities

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk . Please tell us what format you need. It will help us if you say what assistive technology you use.

Annexes

Details

These documents provide guidance to help NHS England in the assessment and determination of applications to provide NHS pharmaceutical services under the new market entry test and the new performance sanctions regime.

This guidance refers to the NHS (Pharmaceutical Services and Local Pharmaceutical Services) Regulations 2013

Published 8 November 2013